Spinal cord arteriovenous shunts (SCAVSs) represent a complex group of lesions, often feared because often misunderstood. The fear is created by the eloquence of the cord, by the poor reputation that SCAVSs carry, because the vascular anatomy of the cord is poorly interpreted and thus still considered difficult.
The rarity of the disease doesn't allow physicians to be confronted often to these lesions. A "rare disease" is a condition that affects a restricted number of persons with regard to the general population. The tolerated threshold for a rare disease in Europe is thus on 1 person on 2000. In France one admits that a disease is rare if less than 30 000 patients are affected. If we consider that definition, SCAVSs do certainly belong to that category.
From a morphological point of view, SCAVSs can be separated in two groups: nidus-type arteriovenous malformations (AVMs) (that can be either intramedullary embedded in the cord, or superficial) and arteriovenous fistulas (AVFs) (always superficial to the cord, either being micro fistulas (mAVFs) or macrofistulas (MAVFs) characterized by giant venous ectasias). SCAVSs described as "glomus type malformations" are sometimes simple arterio-venous fistulas that engorge focally, on a given myelomeric level, the intrinsic and extrinsic venous network, giving thus rise to a pseudo AVM. In order to properly understand these lesions, it is therefore important to analyze precisely the lesional and regional anatomies of the shunt and the surrounding vasculature. The descriptions and interpretations should also take into consideration the evolutive aspects of the shunt that are expressed in the changes and modifications of architecture over time with incidences on both morphology and symptoms, and reflected by recent data on genetics, metameric dispositions, vascular biological features, and angiogenesis (Carmeliet 2000 Risau 1995 Risau , 1997 .
Looking therefore only at the gross "external" aspect of a SCAVS is indeed: -dangerous because the description may vary with physicians; -incomplete because it does not reflect that the shunt is a vascular answer to a trigger acting primarily on an endothelial cell; -erroneous because it does not take in consideration the dynamics of the lesion. Any therapeutic management should be discussed in relation with the natural history of the disease. Little is known about the behaviour of intra-dural SCAVSs in children, and even less in early childhood. If it is grossly circumscribed in adults, the natural history of intra-dural SCAVSs can hardly be extrapolated to the paediatric population. The immaturity at birth of the cerebral venous system in humans has been shown to be an important factor in the presentation of neonates and infants with intra-cranial vascular malformations. The post-natal maturation of the spinal venous system remains poorly understood. It is likely that this system undergoes minor changes after birth compared to the intra-cranial venous system, because the events that normally occur at the level of the spinal cord are the oldest ones in terms of phylogeny and they can be considered as stable programs. However, the joint maturating processes of the vasculature and spinal cord may play a role in the development of the shunt itself and in its revealing symptoms.
All of these data suggest therefore that SCAVSs should be viewed differently. The recent classification that we have proposed (Rodesch 2002 ) takes in consideration these data and tries to present objective solutions for delineation of these lesions.
Etiology of presenting clinical symptoms of intradural SCAVSs
At least two questions raise when one analyses the symptoms created by intradural SCAVSs: why do they become symptomatic at a given moment? Why do some lesions preferentially present with haemorrhage whereas others with progressive symptoms?
Answers can be imagined if one takes in consideration the concept of "host". This working hypothesis, expressed initially by Lasjaunias and Berenstein at the beginning of their experience in brain AVMs in the 80's, is based on the idea that two lesions that might look identical from a morphological point of view can have different natural histories because they are dependant from the host in which they develop. The clinical symptoms will thus not be created by the lesion but by the host itself. This concept postulates that there are no aggressive lesions but only weak hosts. As a corollary of this concept, one could hypothesize that a lesion embedded in the nervous parenchyma is asymptomatic as long as it is in equilibrium with the surrounding vasculature. Haemorrhage occurs if an imbalance concerns primarily the lesion; clinical symptoms (as seizures or progressive neurological deficits) happen if the brain vasculature fails to compensate the effects of the shunt. Architecture reflects the ageing of a lesion, as several morphological changes will be grafted with time on the initial pathological network constituting the shunt, ending in changes in its aspect and strength.
Analysis of the architecture was thus supposed to permit detection of potential weaknesses in the vascular system and to identify stigmata of previous events. Clinical events were suspected to correlate with the architecture.
-Haemorrhages in intra-dural SCAVSs can theoretically result from various causes and are of two types: subarachnoïd haemorrhages (SAH) and hematomyelias (HMM). SAH may occur by rupture of posterior spinal veins that are all located in the sub-arachnoïd space, unlike the anterior spinal vein which is situated in the sub-pial space , Maillot 1996 , Nicholas and Weller 1988 . More rarely, SAH is due to rupture of proximal dissecting aneurysms located on the sub-arachnoid segment of a radiculo-pial or radiculo-medullary artery. If haemorrhagic venous infarcts can be evocated as hypothetic causes of HMM, they could never been precisely proven. The richness of the collateral intrinsic venous network may not favourize this phenomenon.
The higher frequency of bleeding in cervical AVMs is poorly understood: some authors postulate that it is the supra cardiac position that influences the haemorrhagic presentation. The hemodynamic conditions at that level can be indeed likened to the intracranial space, whereas thoraco-lumbar SCAVS' hemodynamics may be counterbalanced by thoraco-abdominal pressures. No definitive proof or satisfactory explanation has however been given till now for these data.
When we reported our series from Bicêtre earlier (Rodesch et Al 2004) , we found out a difference in haemorrhage between children and adults (with bleeds more frequent and rates of HMM higher in the pediatric population) that accorded with data in other studies Emery et Al 1998; Rodesch et Al 1993 , 1995 Scarff and Reigel 1979) . There was no difference between the rates of HMM and SAH in children (52% of HMM and 48% of SAH) but it was evident in adults (respectively 36% of HMM and 64% of SAH). This reflects the anatomical weakening of the disposition previously described and the fact that sub-arachnoid veins are more delicate due to an ageing phenomenon. The severity of initial symptoms in HMM is attributed to the destruction of cord tissue by the haematoma, the less severe clinical signs seen in SAH being due to an impairment of the neural function because of the sub-arachnoid nature of the bleed, but with absence of vasospasm since the cord arteries are mostly sub-pial. In our series, spontaneous improvement was most often observed in both circumstances (in more than 70% of cases), in both populations and in any localisation, so that the poor prognosis for these haemorrhagic episodes, most probably of venous origin, has to be questioned, as in BAVMS (Hartmann et Al 1998) .
Early rebleeds were rare and were mostly due to rerupture of an associated false aneurysm.
We postulated as corollary of all these data that haemorrhagic SCAVSs are not to be treated in emergency in most of the cases. Recovery occurs usually within a couple of months after the acute bleed, and proper treatment can then be proposed in adequate technical and clinical conditions. In our series (Rodesch 2004 ), analysis of the relations between haemorrhages and angio-architectural factors showed no difference between the most frequently encountered factors in children and in adults (pial venous reflux, arterio-venous fistulas, venous ectasias). Only distal arterial aneurysms (AA) were more frequently seen in adults. False aneurysms, either arterial or venous, pointed by definition to the site of haemorrhage.
-The association of AA with SCAVSs is of great interest by analogy to brain AVMs (BAVMs) as they have been considered to be a risk factor for haemorrhage , Konan et Al 1999 . Meisel in 2000 reviewed 662 consecutive BAVMs from the Bicêtre data base, and came to the conclusion that associated aneurysms, whatever their size, aspect and location were not significantly associated to a risk of haemorrhage at presentation. Restricting the physio-pathology of haemorrhage to only purely hemodynamic or mechanical bases seemed thus unsatisfactory. These findings relativized the concept of the mechanical origin of clinical events in brain AVMs. SCAVSs may be submitted to the same rules. In our series indeed, the proportions of haemorrhagic SCAVSs with or without an AA were very close. Also in the specific population of intradural SCAVFs, no aneurysm was ever detected in patients who had bled, although haemorrhages were frequent. Flow phenomena seem unlikely to be solely responsible for the appearance of AA, as they were never associated to any high-flow MAVF.
We suggest therefore that, as for a BAVM (Mansmann et Al 2000, Meisel et Al 2000) , an AA associated with a SCAVS is not linked to a significant proportion of having presented with an hemorrhagic episode. Associated AA found at presentation are, however, different in terms of risk factors evolving over time.
-Venous ectasias are venous channels that focally enlarge because of increased flow. They may dilate at the level where they leave the sub-pial space (where AVMs are located) to become sub-arachnoïd. Statistical analysis shows that there is no significant difference between the percentage of haemorrhage among patients with VE and without VE.
-AVFs, either within a nidus or isolated, more rapidly produce venous congestion and ectasias; yet there is no significant difference between the percentage of haemorrhage with AVF and without AVF Neither anatomical nor mechanical factors seemed to be an appropriate explanation to the occurrence of haemorrhages in adults and children. Acute rupture could be due to an underlying biological or cellular weakness and to a more unstable or weak balance existing between the lesional and regional vasculature, as to the inability (or immaturity) of the latter one to compensate the effects of the shunts. Architecture has therefore to be considered as a response of the host in terms of individual biological susceptibility, age-group vulnerability and timing of application and duration of stress triggers. A clinical event as haemorrhage in a patient harbouring an intra-dural SCAVS may represent an acute failure of the vascular system biology of that given patient at the moment where bleeding occurs.
-A small number of adults and children had acute, non-haemorrhagic symptoms. Abrupt non haemorrhagic deficits represent thrombosis of parts of the malformation or acute hemodynamic changes occurring within the lesion, disrupting the equilibrium between the SCAVS and the cord (Berenstein and Lasjaunias 1992; Rodesch et Al 1993 , 1995 .
-Progressive neurological symptoms are a common finding but their cause remains a debate. Arterial steal is sometimes considered to be a key factor explaining the onset of clinical signs (Bandyopadhyay and Sheth 1999). It was never proven in this series of SCAVSs, even in high flow MAVFs that are theoretically the "ideal" lesions which might deprive adjacent territories of their blood. The normal vasculature of the neighbouring neural territories could always be demonstrated by selective study of their arterial supply and of the perimedullary anastomoses. Pial venous reflux is a common finding with each type of SCAVS. Venous congestion is the most important factor producing progressive symptoms and signs which result from engorgement of the draining channels, responsible for venous myelopathy. As a result of transmedullary anastomoses and rich intrinsic and extrinsic draining networks , Thron 1988 ), congestion may not be limited to a segment of the cord, causing the so-called "referred symptoms" remote from the shunt and different from the arterial territories of the involved feeders. If there is no venous thrombosis, and if the drainage soon finds patent radicular veins, normal cord circulation will be more likely to be preserved. If the venous constraint lasts for a long time, the congestion will end in cord anoxia and atrophy, with fixed symptoms and signs that will not improve even after successful treatment. It is therefore essential to diagnose SCAVSs at an early stage and not to overlook slight neurological disorders that may represent the beginning of more complex and severe clinical problems.
The therapeutic management of intradural SCAVSs
The debate on therapeutic management is impassioned (Spetzler et Al 2002 , Barrow 2002 , Lasjaunias 2003 and leads to controversy. Total eradication of intradural SCAVSs, whatever their type or location, is sometimes advocated in order to avoid their long term consequences (Cogen and Stein 1983; Detweiler et Al 1999; Malis 1982; Ohata et Al 1999; Spetzler et Al 1989 , and it has been considered that only surgery is capable to achieve this goal (Spetzler 2002 Yasargil et Al 1975 , 1984 . Deeply situated intra-medullary shunts are thus considered extremely challenging, and surgery has been often restricted to superficial lateral or dorsal SCAVSs (Huffmann et Al 1998) .
Surgery has not been considered in our series as the primary therapeutic option for intra-dural SCAVSs; it has been reserved to selected cases: filum terminale shunts (because of the distal vascularisation exclusively taken in charge by the anterior spinal artery, usually thin and tortuous in these cases), or small superficial shunts posteriorly located and easily accessible.
Three main reasons have lead to make this choice: -the difficulty to identify surgically the precise zone of arterio-venous shunt amongst the dilated veins -the difficulty to dissect SCAVMs from the cord parenchyma, and to respect thus the normal vasculature and nervous tracts in order to avoir any damage and complications.
-the fact that what is usually described radiologically as a "nidus" is in reality often a mixing of pathological vessels, collateral angioectasic normal circulation, and angiogenetic response to ischemia or haemorrhage.
To consider that all the vessels seen at angiography represent a target that has to be eradicated seems a mistake and may explain the high rate of post surgical complications reported in some series.
Endovascular therapy has frequently been restricted only to preoperative devascularisation of both AVMs and AVFs ( The catheters required to deliver the coils are too rigid to be used for endovascular navigation in the great majority of SCAVSs fed by tortuous arteries. The occlusion is then proximal and cannot control the lesion, especially if the lesion is of nidus-type because collateral circulation distal to the coils develops and prevents future safe approaches. Combined treatments with glue and coils (Nimii and Berenstein 1999) have been performed but this association is limited to anecdotic reports. Unfortunately, long term follow up of patients treated with all these materials is not available in the literature.
Embolisation with glue as sole treatment for SCAVSs is rarely performed and reported (Berenstein and Lasjaunias 1992, Berenstein et Al 2004, Radek et Al 1996 , Tissen 2003 ). Glue has been promoted by late Professor Pierre Lasjaunias for the treatment of arterio-venous shunts for more than 30 years, whatever their localization. Endovascular therapy is more amenable to treat SCAVSs because angiographic analysis and endovascular approach distinguishes better the pathological from the normal vasculatures. The challenges raised by eloquence of surrounding tissues do not apply the same way to endovascular treatments than to surgical ones: selective catheterization and embolisation of anterior spinal artery collaterals can often be achieved safely if one follows precise anatomical guidelines. They require superselective catheterisation of these branches and proper delivery of glue exclusively into the pathological feeder with respect of the normal vasculature of the cord and preservation of the continuity of the anterior spinal axis.
Glue has been exclusively used in this series since the unrewarding results obtained in the early 80's with particles. NBCA has been considered previously to be a "dangerous "agent (difficulty in handling, unpredictable behaviour, risk of erratic embolus, risk of getting glued in the vessel, damage to the eloquent cord…). We consider however this embolus as: -safe and harmless if one follows its rules of manipulations (Berenstein 1981, Berenstein and Choi 1990, Berenstein and Lasjaunias 1992), -the agent of choice because it affords the best stability over time.
Complications occurring during endovascular treatments with glue are not related to the nature of the embolic material but to its poor utilization. Glue has been used in this series in both SCAVMS and SCAVFs, whatever their type and location, with few technical or clinical problems. Our indication for embolisation with glue is based on an analysis of the patient's clinical history and neurological status related to angio-architectural features and vascular anatomy. A morphological target (i.e., partial or complete obliteration) and a therapeutic goal can thus be set. Our therapeutic protocols have been kept unchanged since 1982: they have been set up by Pierre Lasjaunias, and we have continued to apply them in Hôpital Foch. Careful analysis of the anatomy involved , Thron 1988 ) determines the end points of the procedure, the technique to be used and the sequence of sessions to be proposed to the patient. SCAVSs must be disconnected selectively at the level of the shunt itself to obtain satisfactory clinical and radiological results. Histoacryl* must be delivered within the nidus or at the fistulous point. To maintain the collateral circulation to the greatest possible extent, we do not to embolise different feeders supplying different territories during the same session (i.e. a radiculopial and a radiculo-medullar artery). All procedures are performed under general anaesthesia, without any provocative tests. These tests, as the per-procedure use of somato-sensory evoked potentials, has been promoted by certain authors Berenstein 1999, Nimii et Al 2004) . We consider them controversial with regard to the prevention of intra operative complications. No test can predict the way the glue will be delivered. False positive and false negative results have been described , and these tests have not proved to offer more than careful anatomic analysis and appropriate embolisation. The immediate results obtained in our series are similar to those reported by other groups using provocative tests (Nimii et Al 2000) , even when the anterior spinal artery is involved.
The patient's spontaneous clinical improvement noted in our series had not been emphasized previously in the literature; the severity of symptoms created by a spinal cord haemorrhage, and the fear induced by the cord pathology have indeed often lead to rapid and heroic procedures.
Emergency endovascular or surgical treatments are rarely planned by our group in acute haemorrhagic phase, as spontaneous recovery is frequent after haemorrhage in any type of lesion and in any localisation. Spontaneous recovery has occurred within a few weeks or months after the initial bleed. Neurological improvement should thus be expected and favourized by early physiotherapy. In our series, 61% of patients had before embolisation a Karnovski performance score (KPS) above 80, and 39% were below 80. These spontaneous changes could suspect the potential venous origin of the bleed, which is a low pressure bleed ; the cord damage is thus less important than the one occurring during a high pressure arterial haemorrhagic stroke.
Two facts have guided our management strategy, one being derived from our experience with BAVMs: -It has been the rule in our neurosurgical group to be rather conservative as a first step management in haemorrhagic BAVMs. The patient is operated only if he does not tolerate his haematoma and worsens clinically rapidly, or is directly in a severe neurological status. In all other cases, conservative treatment is proposed with close follow up, and treatment is performed when the acute phase has been overstepped with a reduced or normalized intracranial pressure. Therapy is thus facilitated: if surgery is decided it will be performed on a "relaxed" brain ; if embolisation is chosen, trans-arterial navigation is facilitated because of the normalized intracranial pressure and the less spastic reaction of the arteries. Embolisation is favourized as first therapy by our group, and will take place usually 6-8 weeks after the bleed, when the "intracranial storm" will have passed and when the blood-brain-barrier will be healed. This strategy has been extended to haemorrhagic intradural SCAVSs, and we observed empirically that spontaneous improvement took place within this period.
-We have seen, among the patients included in our study group, severe clinical impairments associated to mediocre operative outcomes occurring after attempts for early surgery in haemorrhagic SCAVSs. This strategy is therefore not adopted by our neurosurgical group.
-At the very beginning of our experience with intradural SCAVSs, attempts to embolise these lesions at the acute phase have often failed because of the spastic reactions of the arteries during catheterisation and the impossibility to reach a safe position for embolisation. Early treatments were thus abandoned and delayed therapies were proposed, usually also 6-8 weeks after the haemorrhage. Improvements were noted during these periods.
-Foreign patients sent to us were not treated during the acute phase as they could not be transferred to our departments because of administrative problems. We observed that they improved during the waiting period.
The regroupment of the empiric data noted from single patients has thus helped us to confirm the spontaneous changes for the better in the cohort of haemorrhagic patients.
Endovascular treatment is best performed on a clinically improved patient (who has begun his recovery or has recovered), or on a relaxed cord, and when the equilibrium between the pathological vasculature and the surrounding vessels is re-established. Embolizing in emergency might furthermore be dangerous: the literature reports that emergent embolisation in haemorrhagic SCAVSs carries a high risk of complications and is followed by poor clinical results ( Defreyne et Al 1999).
-We suggest however to try to treat rapidly SCAVSs detected in neonates and infants in order to avoid any damageable interaction between the shunt itself and the maturation of the cord, similar to what is proposed in BAVMs in these populations . This has occurred in our experience when a large threatening false aneurysm was detected, or when it was thought that the lesion could be cured in one session of embolisation, allowing thus a rapid normalization of the cord hemodynamics (Rodesch et Al 1997 , 2003 -Urgent treatments have to be favourized in non haemorrhagic rapidly progressive symptoms. The latter are due to the venous myelopathy: rapid embolization or, if needed, surgery according to the same indications previously described, brings thus to decongestion of the venous system and improvement of the symptoms.
It could be objected that, in order to be considered as an alternative treatment, endovascular therapy has to offer results that are identical to the surgical ones or eventually better than those obtained by operative management, and that such conclusions can only be drawn from randomized studies. We felt however difficult to submit our patients to this kind of study because of the rarity and the gravity of the disease, and because of the differences in interpretations of the lesions by various teams. As no overall statistics is available, we have to look at intra-dural SCAVSs in terms of classification, host, and architecture. We confronted therefore the results from our series characterized by its homogeneity (in analysis and treatment) with those reported in the literature for similar lesions, and found out that our endovascular management compares favourably: -with the natural history of untreated intradural It has been emphasized in the neurosurgical literature that a good clinical outcome and protection against further devastating events is only obtained if morphological cure of the shunt can be achieved. In our Bicêtre series of patients managed transarterially, 16% of lesions could be cured, and 80% of lesions were embolized more than 50% . The best anatomical results were obtained with SCAVFs because of their more simple architecture. These uncomplete morphological results have to be counterbalanced by the satisfactory clinical outcomes: 83% of all these patients have after embolisation a KPS above 80 at long time follow up: 15% are asymptomatic , 42% are improved and 26% are stabilized . The discrepancy between the anatomical and the clinical results contradicts the previously expressed dogma . There is no significative clinical difference between a morphological exclusion and a partial completed targetted embolization (p*=0,28).
In SCAVSs, as in brain AVMs (Meisel et Al 2002) , our experience proves that a well conducted targetted partial endovascular therapy brings to a safe and long lasting protection of patients . Angiography is able to point to the pathological segments responsible for the symptoms and embolisation is thus able to disconnect them selectively. The debate on intranidal AA remains open: in our series disconnection of AA did not frankly correlate to significant improvement after embolisation (p*= 0,06) and one can argue that there is no clear evidence that only their eradication protects patients from future bleeds. However, we consider them as priority targets for embolisation as this assumption has succeeded in reducing the frequency of haemorrhages. The natural history of intradural SCAVSs associated to AA is worse (with recurrent bleedings) than the natural history of SCAVSs that have been submitted to embolization targetted on the associated aneurysm(s). Results of embolization were not dependant from the localization of the shunt (p*= 0,70); nor from disconnection of arterio-venous fistulas and venous ectasias. Embolising a false aneurysm is protective for re-haemorrhages but not for direct clinical improvements (Garcia-Monaco et Al 1993). Pial Venous Reflux (PVR), a common factor in all intradural SCAVSs, is still present after embolisation but it is reduced as the venous system becomes less congested.
This post embolisation clinical improvement is however significantly related to the age of the patient as children do recover better than adults (p*=0,02) . Analysis of our results shows thus that endovascular therapy seems most effective in the paediatric population and after decongestion of the venous drainage. A new haemodynamic equilibrium is thus locally induced with an improved or normalized tolerance of the shunt by the normal vasculature of the cord. The clinical improvement noted after embolisation in our series concerns all neurological functions that were impaired preoperatively: sensori-motor and sphincter control (e.g., bowel, bladder and sexual function). Sphincter dysfunction was seen in 29% of our patients before embolisation. This latter deficit recovered differently according to its pathophysiology. In the progressive congestive forms, the improvement included the sphincter disorders. In the haemorrhagic forms at the level of the conus, a sphincter function that was lost was not recovered.
One should therefore leave the theory of the absolute cure of an image (even at the price of a morbidity to assure protection to a potentially devastating event), for the long term stabilization of the clinical history by targeted embolisation, even with a malformative reliquat. Morbidity following haemorrhage in intra-dural SCAVSs is different and eventually more severe than the morbidity related to ruptured BAVMs. The handicap related to the neurological impairment, and the poor compensations by the effectors contributes also to these differences. However the prevention of a risk of an event to occur should be hampered by the absence of a related morbidity resulting from that event: the therapeutic aggressivity (and the associated morbidity linked to the therapeutic strategy) one develops for mastering intra-dural SCAVSs has to be put in balance with the spontaneous morbidity due to the lesion, and with the frequency of occurence of that event. Our philosophy of treatment favourizes the clinical outcome at the expense of an angiographic image of a potential residue that is often harmless. Recognition of vessels or compartments "not to touch" (representing only an answer of the normal vasculature to a previous trigger) allows to avoid devastating clinical complications.
When embolization was felt completed, no patient has worsened at long term follow up or has rebled, even if remaining partially treated. The resolution to stop the treatment at a given moment is difficult at it has to rely on the same decisional tree than the one bringing to treatment: symptoms, architecture and anatomy. We recommend that when all worrying architectural factors of an intradural SCAVS have been eradicated or mastered, and when the patient's clinical status is at least stabilized, endovascular therapy should be interrupted and the patient followed up in consultation. In the theoretical case he would impair, new sessions should be proposed. In our experience, this has never been necessary till now after completion of the treatment.
We have never seen a lesion cured by embolisation with glue that has reopened.
We therefore consider that long term angiographic controls are unnecessary if a patient with an intra-dural SCAVS is cured and clinically normal or stable after embolisation, specially in the paediatric population. Patients sent from foreign countries and who were incompletely cured despite a well-conducted endovascular therapy that was felt completed were asked to recontact our team directly or via their referring physician if impairment of their neurological status would happen. This has however never occurred till now at long term follow up. Local patients that are partially treated are followed up in consultation, in order to understand their evolution, and assess the need for further imaging or treatments according to their clinical status.
Failure of stabilisation by embolisation occurred in 4% in our series . They presented initially with intense wide-spread peri-lesional high signals visualized on T2-weighted MRI studies that showed ischemia of the cord with perhaps already gliotic reactions, thus explaining the poor results of embolisation. Control MRI performed in one of these patients showed progression toward cord atrophy. Two hypotheses may explain the transitory complications some of our patients experienced : focal post embolisation cord oedema, or impairment of the venous drainage i.e., slowing of the venous flow with «sludge phenomenon». The immediate angiographic results led us to suspect or anticipate the complication that occured, and we proposed an adequate treatment: corticosteroïds for oedema, or anticoagulation therapy, mainly heparin ( eventually followed by oral anticoagulation) if the symptoms were considered to be of venous origin). Retrograde thrombosis of spinal cord arteries has been reported after surgery (Heros et Al 1986) but has not been seen after embolization in our series.
Permanent complications with disability (13% in our series: 4% severe and 9% moderate complications) occured in various circumstances including mainly post -embolisation venous thrombosis (with poor results after anticoagulation therapy) or erratic embolus of glue, mainly when embolized via the anterior spinal artery. All the patients who had complications had their lesion disconnected to at least 50%, or cured. In all of these patients, treatment was thought to be justified because of previous haemorrhages or rapidly progressive neurological symptoms.
The clinical results obtained have all confirmed their stabilisation: no patient has bled or rebled, no patient has worsened after embolization was felt completed. The follow up extended to 2009 has thus shown its stability.
We still have never seen a SCAVS considered cured, reopen at control angiograms, nor seen a patient considered cured from his SCAVS worsen at follow up. Our data support therefore that endovascular treatment with NBCA definitely offers good anatomical and clinical results, improvement or stabilisation of the patients' clinical status in most of the cases, protection from haemorrhagic events, long term effects obtained with a low rate of operative morbidity, and reduction of the therapeutic sessions (1,5 vs. 4,5 with particle embolization [Biondi et Al 1990 , 1992 ). The absence of recanalisation remains remarquable compared with other series of patients with the same types of lesions embolised with different materials.
Therapeutic abstention is part of our management if no satisfactory clinical or anatomical outcome is achievable. The decision not to treat is a therapeutic decision which is "moment related". It does not obligatorily mean that the patient is condemned or incurable, and should be abandoned. It means that at the given moment where the SCAVS is detected, data are lacked (in knowledge, understanding or technique) to propose an appropriate and safe treatment and that it is decided not to take any surgical or endovascular risk in order not to harm the patient, or in order not to compromise safe future attempts. New acquaintances in anatomy or biology, and continuous technical progresses have helped to improve our understanding of SCAVSs and our endovascular navigations. Thanks to these observations, lesions are treated nowadays when they were not some years ago because of poor comprehension of the disease, or no disponibility of appropriate catheters and guides to approach super-selectively the shunt.
These patients are regularly seen in consultation and their clinical course is followed so that an appropriate treatment can be proposed in accordance with the latest therapy advances.
Fifty two patients with SCAVSs have been referred to us in Hôpital Foch between march 2002 and june 2009. Thirty five of them had bled, and eighteen suffered of progressive neurological symptoms. Embolization with glue has been performed in 33 of these patients, 15 of them via the anterior spinal axis. Endovascular treatment failed in 8 patients because of technical difficulties to approach the lesion, and it was decided not to treat these patients at that stage. In 3 patients we performed only angiography and no treatment : one lesion had spontaneously thrombosed and two patients had stable unreachable reliquats after embolization that we had previously performed in Bicêtre. Our opinion about the therapeutic management was asked in 8 patients; treatment was then either performed by the referring team, or not followed.
Among the 33 patients embolized in Foch, anatomical cure was obtained in 6 patients (18,2%) . Occlusion of 75-100% of the shunt was reached in 10 patients (30,3%), of 50-75% in 9 patients (27,3%) and of less than 50% in 24,2%. Haemorrhage occurred in 1 patient who had never bled between two sessions of treatment. The bleed occurred from a compartment that had not been embolized previously. In one other patient with a complex diffuse cervical intramedullary AVM previously embolized with particles by other teams, haemorrhage recurred 6 years after the first bleed, from a tortuous ectatic draining vein in the posterior fossa, , and despite a targetted embolization that we performed with glue on an intranidal aneurysm.
Twelve of these 33 embolized patients improved after treatment (36,4%), and are for 11 of them at grade 90 on the KS. Eighteen patients have stabilized (54,5% : 1 is KS 100, 9 are KS 90, 3 KS 80, 2 KS 70 and 3 KS 40). Overall satisfactory clinical results have thus been obtained in 91% of our patients.
Four patients have worsened transitorily (12 %): their impairment was considered related to "sludge phenomena" in three of them: they all improved under anticoagulation. One severely paraparetic child with a macrofistula worsened after cure by embolization because of the increased mass effect of the thrombosed venous ectasia on the cord. She improved under corticosteroids and after regression of the compression of the cord. Permanent complications occurred in 3 patients (9%). In one patient, embolization via the anterior spinal axis for a small intramedullary slow flow AVM creating a progressive neurological deficit led to motor dysfunction although the glue seemed properly deposited in the nidus and MR failed to detect any new abnormality in the cord. In one patient with an upper cervical AVM vascularized by the lateral spinal artery and harbouring a false aneurysm because of a previous bleed, embolization disconnected this architectural weakness point and 90% of the AVM compartment in which it was embedded but certainly also a small perforating branch arising in its vicinity as a small infarct occurred on the lateral aspect of the cervico-medullary junction. In the last patient with a large diffuse angiogenic nidus type cervical AVM previously embolized mainly with particles, and tetraparetic, embolization of a lesional compartment in the left hemicord vascularized by the anterior spinal axis performed in order to relieve the venous congestion and avoid future clinical worsening, was followed several days after endovascular treatment by impairment of the motricity of the right arm. The patient poorly recovered and remains currently severely affected.
Alternative treatments
New substitution emboli as Onyx* (MicroTherapeutics Inc, Irvine, California) have been promoted for endovascular occlusion of arterio-venous shunts and have been considered to be safe agents. They have been first used in BAVMs, and secondarily tried in SCAVSs We consider this latter material disqualified when considering SCAVSs: -the mode of delivery necessitates reflux of embolic material around the microcatheter and an injection in a wedged position, which carries a high risk of neurological damage -the deep penetration allowed in the niduses may contaminate through intrinsic anastomoses the normal vasculature of the cord -the catheters needed for Onyx* injections are too rigid and often cannot be navigated distally enough in small tortuous spinal cord arteries -Onyx* cannot be used for high -flow fistulas: these shunts need a rapid and immediate occlusion to be effectively cured, and the polymerisation time of Onyx* is too long as it always has to be diluted.
-the long -term efficacy of these material, derived from an old Japanese embolic agent abandoned nowadays because of its toxicity, is unclear.
Other materials have been tried recently but one has to consider them only as anecdotic cases reports (Sugiu et Al 2001) Radiotherapy (conventional, or delivered in stereotactic conditions ) has in our eyes no place in the treatment of intradural SCAVSs. Cyberknife, a new radiosurgical tool based on non-invasive image -guided localization of lesions and on a frameless robotic delivery system, is described by the manufacturer as supposed to overcome the limitations of Gamma Knife and Lineac (Chang et Al 1998) and to allow irradiation of SCAVSs. No report of satisfactory treatment has ever been published in the literature. We do not recommend or consider this type of management at this stage because of the eloquence of the nervous tissue and the physiological pulsatility of the cord itself during the procedure that might preclude precise targeting of the radiation.
Proposed Guidelines of management of a symptomatic SCAVS
The proper diagnosis of intradural SCAVSs is based nowadays on MRI and angiography. A patient with spinal cord symptoms is first studied by MRI. A vascular malformation is easily confirmed when intra-medullary or peri-medullary vascular dilatations are detected. However, micro-lesions embedded in the ventral sulcus of the cord may not present with the classical MR features but with an hypersignal on T2-weighted images located in the anterior portion of the cord without any vascular enlargement, as the arterial feeder, the shunt and the draining vein remain exclusively subpial (Lasjaunias et Al 2000).
Angiography confirms the vascular malformation and analyzes the lesional and the regional vascular anatomy: all the potential vascular sources of supply to the shunt (lesional vascular anatomy) will have to be determined according to angiographic protocols that will also study the vascularization of the surrounding myelomeres and rebuild the arterial continuities, mainly the anterior spinal artery (regional vascular anatomy). One will thus confirm the interactions between both pathological and normal vasculatures.
Several clinical situations can be encountered: -Acute symptoms related to a SCAVS require emergent MRI to rule out the haemorrhagic or non haemorrhagic aspect of the lesion.
It is suggested to first analyze an haemorrhagic SCAVS by MRA (Condette -Auliac et Al 2005; Maschalchi et Al 1995 . No treatment is needed at that stage. In adult patients or in grown up children, we propose to wait for recovery which will begin in most of the cases within a couple of weeks after the bleed. The first diagnostic and therapeutic angiography is usually performed 6 to 8 weeks after the initial dramatic event, except in neonates or infants who should be managed rapidly. Endovascular treatment should be performed with glue: it should eradicate in a targeted way worrying angio-architectural factors (mainly false aneurysms) and bring to venous decongestion. The decision to embolise will be based on the correspondence between architecture, anatomy and clinical symptoms. If total cure cannot be obtained in one session because of anatomical and architectural reasons, further staggered sessions will be proposed.
If MRI confirms that acute symptoms are not related to haemorrhage, spontaneous acute thrombosis of the lesion (in part or in totality) has to be evocated. The clot or thrombus has to be looked for, and, when confirmed, the patient should be first medically treated, mainly with anticoagulation. Recovery usually then occurs within a few weeks. The first session of diagnostic and therapeutic angiography will be proposed 6-8 weeks after the onset of symptoms, except in children below 2 years of age who will be managed rapidly. If the patient does not improve rapidly, diagnostic and therapeutic angiography should be performed according to the same rules described here above. The use of corticosteroids as medical adjunct in the two latter situations remains debatable (Dumont et Al 2001 , Peter Velmann et Al 2003 .
In case of progressive clinical signs related to a SCAVS, MRI will diagnose the lesion and its consequences on the cord, mainly under the form of an high signal on T2-weighted images that witness the cord suffering around the malformation itself. This high signal may extend over several myelomeres, far from the initial lesion, and expresses the outspread venous congestion leading to cord ischemia, oedema or anoxia. The timing of embolization will depend on the symptom progression. The first session of diagnostic and therapeutic angiography should be performed rapidly after the onset of symptoms both in adult and paediatric populations if they are rapidly progressive in order to counterbalance the effects of the shunt : reduce the flow and the venous congestion , and thus the ischemic venous myelopathy. The venous drainage of the cord will then be improved, and conjunction of both phenomena will allow the symptoms to regress partly or fully, as a new haemodynamic equilibrium between the malformation and the cord is installed.
Screening of patients with intradural SCAVSs
Screening is indicated if the diagnosis of a pathological condition involves a hereditary disease (i.e a disease transmitted by parents to their descendants). It aims to detect a pathology that significantly impacts upon public health and before the disease reaches a critical point (i.e. haemorrhage). Detection before this point should confer a beneficial outcome with intervention (surgery, embolisation or radiotherapy). The screening test itself should be sensitive enough to detect the disease, specific enough to minimise false positives and it should be well tolerated with few side effects. The population to be screened should have a high prevalence of the disease, and should be willing to undergo treatment (Al-Shahi 2003). If SCAVSs are concerned, the only malformation filling theoretically these terms is the genetic hereditary MAVF linked to HHT. Screening a patient (or one of his relatives) affected by an intradural genetic non hereditary type of SCAVS, or by a single lesion, has no sense as these diseases are non transmissible.
HHT is characterized by variable age-related expressions, manifestations developing throughout life and later in life, and varying between individuals (even in the same family) ( . International consensus diagnostic criteria have been developed and based on 4 criteria: spontaneous recurrent nosebleeds, muco-cutaneous telengiectasia, visceral involvement and an affected first degree relative (Shovlin et Al 2000) . They define "definite HHT" where 3 criteria are present, "suspected HHT" with 2 criteria (most commonly family history and nose bleeds) or "unlikely HHT" with one criterion. In this latter situation, as in the paediatric population (child of a patient with HHT) , a crucial issue is that no confirmation of HHT can be given unless a molecular analysis is performed (Begbie et Al 2003) . Screening needs to keep in mind the consequences of such a diagnosis and the natural history of central nervous system arterio-venous shunts (CNS AVS) related to HHT. The exact prevalence of CNS AVS is uncertain but estimated 5 -23% for BAVMs Three types of screening can theoretically be considered: -one concerning a relative of an HHT patient with a MAVF, in order to diagnose if he is affected by the same disease -one testing if an asymptomatic patient with HHT harbours a clinically silent AVS.
-one testing if the child of an affected HHT patient has a MAVF.
MAVFs linked to HHT revealed in our series most frequently in the paediatric population . We had seen in Bicêtre an adult patient with a MAVF that was not linked to HHT. If the affected parent would have a MAVF either in the cord or in the brain, it would have revealed during the childhood. There is thus no need to check if the parent suspected to be affected by HHT harbours a MAVF.
The question of submitting this parent to screening for the potential presence of another type of CNS vascular malformation can be answered by the natural history of these lesions and by the therapeutic risks that would be the consequence of the fortuitously discovered silent cerebral shunt.
Because HHT -related BAVMs rarely bleed and the therapeutic risks, even in optimal series, overstep the natural risks, it seems unreasonable to propose screening in these populations.
If a MAVF is found in a child, the diagnosis of HHT will be based on a genealogic tree and on the existing criteria in the family. This has been possible in the paediatric HHT population in our series. The absence of an affected relative may however not exclude HHT as a new mutation may have occurred without family history of HHT. Any doubt would require molecular analysis for confirmation. It seems for all these reasons unproductive and expensive to screen asymptomatic HHT adult patients for brain or spinal cord arterio-venous shunts.
Screening could be more useful in the paediatric population as typical clinical signs usually appear later in life (Mandzia et Al 1999, Plauchu et Al 1989) . Furthermore, most of these children will harbour MAVFs where treatment is indicated and offers good outcome.
In any cases, screening of the patient and affected family members for pulmonary shunts should be proposed (Hatjema et Al 1995, Mandzia et Al 1999, Vase et Al 1985) as they are the main source of CNS complications (strokes or abscesses) in HHT. At a given moment, 15-30% of HHT patients are indeed estimated to have pulmonary involvement.
No de novo appearance of central nervous system (CNS) lesions has ever been reported.
Future aspects of management of intra-dural SCAVSs
-The vascular aspect of these lesions is well diagnosed nowadays but future improvements in MRI will help to recognize and understand better the consequences of the shunt on the cord itself. The progresses will mainly concern:
-the development of new MRA sequences that will delineate more precisely the architecture of the lesion -the MR diffusion weighted imaging (DWI) in the cord that has been shown to detect injury that otherwise would go undetected with conventional MRI. . Imaging of the normal and diseased fiber pathways will be more and more part of the routine MRI examination and will give important informations on the effects of the vascular lesion with regard to the shunt itself and its venous drainage. Important arguments on the potential functional recovery could be brought by these techniques. -The clinical follow up will be extended and will confirm the stability of the results obtained nowadays by endovascular therapy. The regroupment of these data with the angiographic and MR results will help to better deal with the differentiation between normal and pathological vasculatures.
-If these stabilizations are confirmed, the management of the lesions will mainly concern the take in charge of the patient's handicap in order to allow him to be reintegrated in social life. Mechanical and pharmacological methods will have to be developed in that sense (Brunelli 2005 , Heimburger 2005 ).
-If the endovascular treatment proposed nowadays remains an acceptable method to counterbalance the effects of the shunt, it seems nevertheless misadapted as it represents a mechanical way to treat what wan be considered as a biological disease. Future research and studies will have to concentrate on the understanding of the creation of SCAVSs in order to avoid their development. May be then in the future vascular shunts of the central nervous system will be fully controlled and will disappear, as some infectious diseases have already done. 
